Don’t Roll the Dice with MDMA, Part 2
Even one of the researchers for MDMA-assisted therapy acknowledged several problems with the therapy.
Search Results as of: 2024 November 21, 2:34 PM
Even one of the researchers for MDMA-assisted therapy acknowledged several problems with the therapy.
Should the FDA approve MDMA-assisted therapy? Should we roll the dice and see what happens? A recent survey noted Americans have mixed feelings.
In August of 2024, the FDA rejected Lykos’ request to approve MDMA-assisted therapy. Lykos should have been less slipshod in their research.
On December 12, 2023 the MAPS Public Benefit Corporation announced it submitted a new drug application (NDA) to the FDA for MDMA-assisted therapy. MAPS PBC